Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 22, 2008, Pages 10574-10581

  Chen, Tianfeng ^a   Wong, Yum Shing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Akt; Apoptosis; Cell cycle arrest; ERK; MCF 7 cells; Selenium; Selenocystine

Indexed keywords

ANTINEOPLASTIC AGENT; CYSTINE; DRUG DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; ORGANOSELENIUM DERIVATIVE; PROTEIN KINASE B; SELENOCYSTINE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE S PHASE; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CYSTINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; ORGANOSELENIUM COMPOUNDS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; S PHASE;

EID: 57849084052     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf802125t     Document Type: Article

References (36)

1. Perera, N. M.; Gui, G. P. Multi-ethnic differences in breast cancer current concepts and future directions. Int. J. Cancer 2003, 106, 463-467.
2. Zelnak, A. B.; O'Regan, R. M. Chemoprevention of breast cancer. Curr. Probl. Cancer 2004, 28, 201-217.
3. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768-780.
4. Coley, H. M. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat. Rev. 2008, 34, 378-390.
5. Fulda, S.; Meyer, E.; Friesen, C.; Susin, S. A.; Kroemer, G.; Debatin, K. M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 2001, 20, 1063-1075.
6. Rayman, M. P. The importance of selenium to human health. Lancet 2000, 356, 233-241.
7. Sinha, R.; El-Bayoumy, K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr. Cancer Drug Targets 2004, 4, 13-28.
8. Schrauzer, G. N. Anticarcinogenic effects of selenium. Cell. Mol. Life Sci. 2000, 57, 1864-1873.
9. Li, S.; Zhou, Y.; Wang, R.; Zhang, H.; Dong, Y.; Ip, C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol. Cancer Ther. 2007, 6, 1031-1038.
10. Ip, C.; Zhu, Z.; Thompson, H. J.; Lisk, D.; Ganther, H. E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res. 1999, 19, 2875-2880.
11. El-Bayoumy, K.; Sinha, R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat. Res. 2004, 551, 181-197.
12. Chen, T.; Zheng, W.; Wong, Y.-S.; Yang, F. Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative. Biomed. Pharmacother. 2008, 62, 77-84.
13. Chen, T.; Wong, Y.-S. Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed. Pharmacother. 2008, xxxx, (doi: 10.1016/j.biopha.2008.03.009).
14. Chen, T.; Wong, Y.-S. In vitro antioxidant and antiproliferative activities of selenium-containing phycocyanin from selenium-enriched Spirulina platensis. J. Agric. Food Chem. 2008, 56, 4352-4358.
15. Hu, H.; Li, G. X.; Wang, L.; Watts, J.; Combs, G. F., Jr.; Lu, J. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin. Clin. Cancer Res. 2008, 14, 1150-1158.
16. Zhao, R.; Xiang, N.; Domann, F. E.; Zhong, W. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66, 2296-2304.
17. Whanger, P. D. Selenium and its relationship to cancer an update. Br. J. Nutr. 2004, 91, 11-28.
18. El-Sayed, W. M.; Aboul-Fadl, T.; Lamb, J. G.; Roberts, J. C.; Franklin, M. R. Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice. Toxicology 2006, 220, 179-188.
19. Nilsonne, G.; Sun, X.; Nystrom, C.; Rundlof, A. K.; Potamitou Fernandes, A.; Bjornstedt, M.; Dobra, K. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. Free Radical Biol. Med. 2006, 41, 874-885.
20. Pelicano, H.; Carney, D.; Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Update 2004, 7, 97-110.
21. Simstein, R.; Burow, M.; Parker, A.; Weldon, C.; Beckman, B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp. Biol. Med 2003, 228, 995-1003.
22. 2-induced apoptosis in primary rat alveolar epithelial cells. J. Cell. Biochem. 2004, 92, 502-513.
23. McCubrey, J. A.; Lahair, M. M.; Franklin, R. A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal. 2006, 8, 1775-1789.
24. Lawlor, M. A.; Alessi, D. R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses. J. Cell Sci. 2001, 114, 2903-2910.
25. Boldt, S.; Weidle, U. H.; Kolch, W. The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 2002, 23, 1831-1838.
26. Singh, R. P.; Dhanalakshmi, S.; Agarwal, R. Phytochemicals as cell cycle modulators - a less toxic approach in halting human cancers. Cell Cycle 2002, 1, 156-161.
27. Toogood, P. L. Progress toward the development of agents to modulate the cell cycle. Curr. Opin. Chem. Biol. 2002, 6, 472-478.
28. Zhong, W.; Oberley, T. D. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res. 2001, 61, 7071-7078.
29. Wang, Z.; Hu, H.; Li, G.; Lee, H. J.; Jiang, G.; Kim, S. H.; Lu, J. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density. Int. J. Cancer 2008, 122, 15-24.
30. Venkateswaran, V.; Klotz, L. H.; Fleshner, N. E. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Cancer Res. 2002, 62, 2540-2545.
31. Jiang, C.; Wang, Z.; Ganther, H.; Lu, J. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol. Cancer Ther. 2002, 1, 1059-1066.
32. Goel, A.; Fuerst, F.; Hotchkiss, E.; Boland, C. R. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cancer Biol. Ther. 2006, 5, 529-535.
33. Unni, E.; Koul, D.; Yung, W. K.; Sinha, R. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Breast Cancer Res. 2005, 7, 699-707.
34. Lowe, S. W.; Lin, A. W. Apoptosis in cancer. Carcinogenesis 2000, 21, 485-495.
35. Johnson, G. L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912.
36. Hu, H.; Jiang, C.; Li, G.; Lu, J. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 2005, 26, 1374-1381.